US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Altimmune, Inc.

3.11

+0.16005.42%

Post-market: 3.110.00000.00%19:52 EDT

Volume:6.16M

Turnover:19.39M

Market Cap:603.34M

PE:-4.09

High:3.24

Open:2.98

Low:2.95

Close:2.95

52wk High:6.44

52wk Low:2.56

Shares:194.00M

Float Shares:164.00M

Volume Ratio:1.23

T/O Rate:3.75%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.7600

EPS(LYR):-0.9999

ROE:-28.87%

ROA:-17.20%

PB:1.27

PE(LYR):-3.11

Loading ...

Overview Company News Filings

U.S. RESEARCH ROUNDUP-Baldwin Insurance Group, Diamondback Energy, Visteon

Altimmune plans to move headquarters to Morristown, New Jersey from Maryland

Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting

Boehringer - 84.2% Patients on Survodutide Cut Liver Fat by at Least 30% VS 24.3% on Placebo in Synchronize-Masld

THOMSON REUTERS

Boehringer-Zealand's obesity drug shows promise in cutting visceral, liver fat

Boehringer - Survodutide Drug Showed 34% Visceral and 63% Liver Fat Reduction, Minimized Lean Mass Loss

THOMSON REUTERS

H.C. Wainwright Sticks to Their Buy Rating for Altimmune (ALT)

TG Therapeutics Announces Positive Results from Phase 1 Trial Evaluating Subcutaneous BRIUMVI® (ublituximab-xiiy)

TG Therapeutics Announces Publication of Post-Hoc Data from the Phase 3 ULTIMATE I & II Trials in Treatment Naive Patients with Relapsing Forms of MS Published in Frontiers in Immunology

Altimmune reports 48-week data from IMPACT Phase 2b trial of pemvidutide

Altimmune Says Pemvidutide Data Show Metabolic Improvements in MASH Patients

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Altimmune (ALT), Icon (ICLR) and AIM ImmunoTech (AIM)

Altimmune's Phase 2b Trial Data for Pemvidutide Demonstrates Improvements in Liver Disease

MT Newswires Live

Altimmune says pemvidutide shows fibrosis regression in MASH in IMPACT Phase 2b qFibrosis analysis

New IMPACT Phase 2b Data Highlight Concurrent Improvements Across Multiple Non-Invasive Markers and qFibrosis-Measured Fibrosis Regression with Pemvidutide in MASH at EASL 2026

TG Therapeutics Announces Positive Topline Results from Phase 3 ENHANCE Trial

TG Therapeutics Announces Data Presentations for BRIUMVI® at the 2026 Consortium of Multiple Sclerosis Centers Annual Meeting

Several Insiders Invested In Altimmune Flagging Positive News

Simply Wall St.

U.S. RESEARCH ROUNDUP-Costco Wholesale, HCA Healthcare, Micron Technology

Altimmune Is Maintained at Buy by HC Wainwright & Co.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/ALT/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ALT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALT\",,,,,undefined,":{"symbol":"ALT","market":"US","secType":"STK","nameCN":"Altimmune, Inc.","latestPrice":3.11,"timestamp":1787342400000,"preClose":2.95,"halted":0,"volume":6157414,"hourTrading":{"tag":"盘后","latestPrice":3.11,"preClose":3.11,"latestTime":"19:52 EDT","volume":21708,"amount":67555.8523,"timestamp":1787356341006,"change":0,"changeRate":0,"amplitude":0.014373},"delay":0,"changeRate":0.054237288135593115,"floatShares":164000000,"shares":194000000,"eps":-0.76,"marketStatus":"Market Closed","change":0.16,"latestTime":"08-21 16:00:00 EDT","open":2.98,"high":3.24,"low":2.95,"amount":19392450.2815408,"amplitude":0.098305,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.76,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":2.95,"preHourTrading":{"tag":"盘前","latestPrice":2.96,"preClose":2.95,"latestTime":"09:27 EDT","volume":7468,"amount":22288.9718896,"timestamp":1787318831172,"change":0.01,"changeRate":0.00339,"amplitude":0.023729},"postHourTrading":{"tag":"盘后","latestPrice":3.11,"preClose":3.11,"latestTime":"19:52 EDT","volume":21708,"amount":67555.8523,"timestamp":1787356341006,"change":0,"changeRate":0,"amplitude":0.014373},"volumeRatio":1.2261654111173856,"impliedVol":0.6517,"impliedVolPercentile":0.1394},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALT\",,,,,undefined,":{"symbol":"ALT","floatShares":164000000,"roa":"-17.20%","roe":"-28.87%","lyrEps":-0.999873,"volumeRatio":1.2261654111173856,"shares":194000000,"dividePrice":0,"high":3.24,"amplitude":0.098305,"preClose":2.95,"low":2.95,"week52Low":2.56,"pbRate":"1.27","psRate":"19462.58","week52High":6.4399,"institutionHeld":0.5318,"latestPrice":3.11,"eps":-0.76,"divideRate":0,"volume":6157414,"delay":0,"ttmEps":-0.76,"open":2.98,"prevYearClose":3.61,"prevWeekClose":2.94,"prevMonthClose":2.84,"prevQuarterClose":3.04,"fiveDayClose":2.94,"twentyDayClose":2.77,"sixtyDayClose":2.98},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"ALT","fiscalQuarterEnding":"2026/06","expectedEps":-0.15,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"pre","actualEps":-0.12},{"market":"US","date":"2026-05-13","symbol":"ALT","fiscalQuarterEnding":"2026/03","expectedEps":-0.25,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"pre","actualEps":-0.18},{"market":"US","date":"2026-03-05","symbol":"ALT","fiscalQuarterEnding":"2025/12","expectedEps":-0.25,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"pre","actualEps":-0.27},{"market":"US","date":"2025-11-06","symbol":"ALT","fiscalQuarterEnding":"2025/09","expectedEps":-0.29,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.21},{"market":"US","date":"2025-08-12","symbol":"ALT","fiscalQuarterEnding":"2025/06","expectedEps":-0.32,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-0.27}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.6364,"hold":0.0909,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6364,"analysts":11,"updateTime":1782187200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALT","date":"2026-08-21","current":-4.092105,"percent":0.2557,"low":-11.212671,"twenty":-6.456483,"median":-4.961303,"eighty":-3.279387,"high":-1.406077,"avg":-4.950406,"sd":1.929748,"marketCap":573827217},"quantilePoints":[{"date":"2021-08-27","current":-8.542517,"twenty":-9.583629,"median":-1.12906,"eighty":-0.630603,"marketCap":581599443},{"date":"2021-09-03","current":-9.554361,"twenty":-9.558349,"median":-1.132786,"eighty":-0.630952,"marketCap":650488690},{"date":"2021-09-10","current":-9.775338,"twenty":-9.591169,"median":-1.136512,"eighty":-0.630952,"marketCap":665533468},{"date":"2021-09-17","current":-8.862353,"twenty":-9.605176,"median":-1.137989,"eighty":-0.631686,"marketCap":603374780},{"date":"2021-09-24","current":-8.705343,"twenty":-9.600447,"median":-1.155144,"eighty":-0.635355,"marketCap":592685069},{"date":"2021-10-01","current":-6.949155,"twenty":-9.591169,"median":-1.16462,"eighty":-0.638289,"marketCap":473118675},{"date":"2021-10-08","current":-7.077089,"twenty":-9.559679,"median":-1.173775,"eighty":-0.638289,"marketCap":481828810},{"date":"2021-10-15","current":-6.984046,"twenty":-9.554182,"median":-1.181272,"eighty":-0.638815,"marketCap":475494167},{"date":"2021-10-22","current":-6.699101,"twenty":-9.550655,"median":-1.192207,"eighty":-0.641115,"marketCap":456094321},{"date":"2021-10-29","current":-6.280407,"twenty":-9.538907,"median":-1.192406,"eighty":-0.641912,"marketCap":427588426},{"date":"2021-11-05","current":-6.303668,"twenty":-9.536915,"median":-1.195875,"eighty":-0.642691,"marketCap":429172087},{"date":"2021-11-12","current":-5.254536,"twenty":-9.534318,"median":-1.207066,"eighty":-0.645626,"marketCap":440449772},{"date":"2021-11-19","current":-4.989681,"twenty":-9.517742,"median":-1.21849,"eighty":-0.645626,"marketCap":418248884},{"date":"2021-11-26","current":-4.928196,"twenty":-9.492985,"median":-1.222217,"eighty":-0.645626,"marketCap":413095106},{"date":"2021-12-03","current":-4.483618,"twenty":-9.492985,"median":-1.234811,"eighty":-0.645626,"marketCap":375829329},{"date":"2021-12-10","current":-4.455241,"twenty":-9.478066,"median":-1.237122,"eighty":-0.645626,"marketCap":373450662},{"date":"2021-12-17","current":-4.426864,"twenty":-9.474354,"median":-1.242711,"eighty":-0.645626,"marketCap":371071995},{"date":"2021-12-23","current":-4.351191,"twenty":-9.464501,"median":-1.250163,"eighty":-0.64856,"marketCap":364728884},{"date":"2021-12-31","current":-4.332272,"twenty":-9.444757,"median":-1.266932,"eighty":-0.649294,"marketCap":363143107},{"date":"2022-01-07","current":-3.916072,"twenty":-9.429228,"median":-1.270658,"eighty":-0.649294,"marketCap":328255996},{"date":"2022-01-14","current":-3.707971,"twenty":-9.419545,"median":-1.300468,"eighty":-0.649294,"marketCap":310812440},{"date":"2022-01-21","current":-3.305959,"twenty":-9.395156,"median":-1.357281,"eighty":-0.649294,"marketCap":277114663},{"date":"2022-01-28","current":-3.40528,"twenty":-9.375518,"median":-1.896273,"eighty":-0.649294,"marketCap":285439996},{"date":"2022-02-04","current":-3.622839,"twenty":-9.356009,"median":-2.181903,"eighty":-0.649294,"marketCap":303676441},{"date":"2022-02-11","current":-3.632298,"twenty":-9.294535,"median":-2.226131,"eighty":-0.651495,"marketCap":304469329},{"date":"2022-02-18","current":-3.339066,"twenty":-9.255468,"median":-2.240874,"eighty":-0.652962,"marketCap":279889774},{"date":"2022-02-25","current":-3.599191,"twenty":-9.25041,"median":-2.262988,"eighty":-0.65443,"marketCap":301694218},{"date":"2022-03-04","current":-3.277582,"twenty":-9.216158,"median":-2.281416,"eighty":-0.656631,"marketCap":274735996},{"date":"2022-03-11","current":-3.29177,"twenty":-9.164959,"median":-2.299844,"eighty":-0.656631,"marketCap":275925330},{"date":"2022-03-18","current":-3.187041,"twenty":-9.152685,"median":-2.321958,"eighty":-0.656631,"marketCap":309429796},{"date":"2022-03-25","current":-2.824576,"twenty":-9.120812,"median":-2.329329,"eighty":-0.656889,"marketCap":274238058},{"date":"2022-04-01","current":-2.749431,"twenty":-9.069815,"median":-2.351443,"eighty":-0.658485,"marketCap":266942209},{"date":"2022-04-08","current":-2.510734,"twenty":-9.026468,"median":-2.395671,"eighty":-0.660299,"marketCap":243767162},{"date":"2022-04-14","current":-2.31182,"twenty":-9.002244,"median":-2.403042,"eighty":-0.660299,"marketCap":224454623},{"date":"2022-04-22","current":-2.006819,"twenty":-8.981208,"median":-2.373557,"eighty":-0.660299,"marketCap":194842063},{"date":"2022-04-29","current":-1.997978,"twenty":-8.97802,"median":-2.3367,"eighty":-0.660463,"marketCap":193983728},{"date":"2022-05-06","current":-1.913993,"twenty":-8.974196,"median":-2.325643,"eighty":-0.661689,"marketCap":185829544},{"date":"2022-05-13","current":-2.19104,"twenty":-8.962867,"median":-2.314587,"eighty":-0.663967,"marketCap":222734186},{"date":"2022-05-20","current":-2.131593,"twenty":-8.93653,"median":-2.296159,"eighty":-0.664701,"marketCap":216691010},{"date":"2022-05-27","current":-2.13584,"twenty":-8.925681,"median":-2.280878,"eighty":-0.66787,"marketCap":217122666},{"date":"2022-06-03","current":-2.309934,"twenty":-8.905008,"median":-2.27773,"eighty":-0.668807,"marketCap":234820537},{"date":"2022-06-10","current":-3.630503,"twenty":-8.886226,"median":-2.28299,"eighty":-0.668883,"marketCap":369065367},{"date":"2022-06-17","current":-3.830074,"twenty":-8.882388,"median":-2.299844,"eighty":-0.671304,"marketCap":389353170},{"date":"2022-06-24","current":-4.369342,"twenty":-8.86636,"median":-2.31182,"eighty":-0.671304,"marketCap":444173406},{"date":"2022-07-01","current":-4.781223,"twenty":-8.859328,"median":-2.321958,"eighty":-0.671304,"marketCap":486043980},{"date":"2022-07-08","current":-5.379938,"twenty":-8.843395,"median":-2.329329,"eighty":-0.672112,"marketCap":546907391},{"date":"2022-07-15","current":-4.810947,"twenty":-8.833277,"median":-2.3367,"eighty":-0.673733,"marketCap":489065568},{"date":"2022-07-22","current":-5.554032,"twenty":-8.79056,"median":-2.3883,"eighty":-0.674765,"marketCap":564605263},{"date":"2022-07-29","current":-5.099688,"twenty":-8.752462,"median":-2.431168,"eighty":-0.674972,"marketCap":518418135},{"date":"2022-08-05","current":-5.26529,"twenty":-8.743932,"median":-2.458327,"eighty":-0.677129,"marketCap":535252696},{"date":"2022-08-12","current":-8.685942,"twenty":-8.727192,"median":-2.479782,"eighty":-0.678611,"marketCap":841987671},{"date":"2022-08-19","current":-8.585874,"twenty":-8.767651,"median":-2.479782,"eighty":-0.678611,"marketCap":832287353},{"date":"2022-08-26","current":-9.231316,"twenty":-8.857064,"median":-2.479782,"eighty":-0.678611,"marketCap":894854409},{"date":"2022-09-02","current":-11.212671,"twenty":-8.915344,"median":-2.479782,"eighty":-0.678611,"marketCap":1086920721},{"date":"2022-09-09","current":-9.996839,"twenty":-8.976745,"median":-2.479782,"eighty":-0.678611,"marketCap":969061848},{"date":"2022-09-16","current":-6.839679,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":663016789},{"date":"2022-09-23","current":-6.189234,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":599964717},{"date":"2022-09-30","current":-6.453807,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":625611519},{"date":"2022-10-07","current":-5.28636,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":512442952},{"date":"2022-10-14","current":-5.256037,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":509503508},{"date":"2022-10-21","current":-5.422815,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":525670447},{"date":"2022-10-28","current":-6.453807,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":625611519},{"date":"2022-11-04","current":-5.983796,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":580050148},{"date":"2022-11-11","current":-6.042666,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":525366485},{"date":"2022-11-18","current":-4.996929,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":434447121},{"date":"2022-11-25","current":-5.138245,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":446733522},{"date":"2022-12-02","current":-6.376172,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":554362390},{"date":"2022-12-09","current":-5.709161,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":496370580},{"date":"2022-12-16","current":-6.489225,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":564191510},{"date":"2022-12-23","current":-8.665489,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":753402078},{"date":"2022-12-30","current":-9.298584,"twenty":-9.046009,"median":-2.479782,"eighty":-0.678611,"marketCap":808445152},{"date":"2023-01-06","current":-8.077615,"twenty":-9.046009,"median":-2.550468,"eighty":-0.678611,"marketCap":702290652},{"date":"2023-01-13","current":-9.208142,"twenty":-9.082964,"median":-2.674285,"eighty":-0.678611,"marketCap":800581856},{"date":"2023-01-20","current":-8.111531,"twenty":-9.082964,"median":-2.74501,"eighty":-0.678611,"marketCap":705239388},{"date":"2023-01-27","current":-7.478436,"twenty":-9.082964,"median":-2.834635,"eighty":-0.678611,"marketCap":650196314},{"date":"2023-02-03","current":-8.569394,"twenty":-9.082964,"median":-3.041104,"eighty":-0.682837,"marketCap":745047326},{"date":"2023-02-10","current":-7.591488,"twenty":-9.082964,"median":-3.089794,"eighty":-0.692599,"marketCap":660025434},{"date":"2023-02-17","current":-6.760551,"twenty":-9.082964,"median":-3.29177,"eighty":-0.706713,"marketCap":587781399},{"date":"2023-02-24","current":-6.771856,"twenty":-9.082964,"median":-3.329607,"eighty":-0.719867,"marketCap":588764311},{"date":"2023-03-03","current":-6.742082,"twenty":-9.082964,"median":-3.358746,"eighty":-0.742102,"marketCap":571141998},{"date":"2023-03-10","current":-6.032389,"twenty":-9.082964,"median":-3.414739,"eighty":-0.768114,"marketCap":511021788},{"date":"2023-03-17","current":-6.404687,"twenty":-9.082964,"median":-3.495141,"eighty":-0.78253,"marketCap":542560259},{"date":"2023-03-24","current":-2.513011,"twenty":-9.082964,"median":-3.5046,"eighty":-0.796016,"marketCap":212884679},{"date":"2023-03-31","current":-2.454839,"twenty":-9.080548,"median":-3.499871,"eighty":-0.802556,"marketCap":207956793},{"date":"2023-04-06","current":-2.251239,"twenty":-9.080548,"median":-3.499871,"eighty":-0.804482,"marketCap":190709192},{"date":"2023-04-14","current":-2.681708,"twenty":-9.082964,"median":-3.5046,"eighty":-0.809804,"marketCap":227175549},{"date":"2023-04-21","current":-3.33323,"twenty":-9.082964,"median":-3.5046,"eighty":-0.816048,"marketCap":282367873},{"date":"2023-04-28","current":-2.885309,"twenty":-9.085381,"median":-3.51872,"eighty":-0.82152,"marketCap":244423150},{"date":"2023-05-05","current":-2.873674,"twenty":-9.085381,"median":-3.51872,"eighty":-0.831857,"marketCap":243437573},{"date":"2023-05-12","current":-3.100543,"twenty":-9.085381,"median":-3.51872,"eighty":-0.840814,"marketCap":262656329},{"date":"2023-05-19","current":-2.569103,"twenty":-9.085381,"median":-3.51872,"eighty":-0.844264,"marketCap":219290931},{"date":"2023-05-26","current":-2.431202,"twenty":-9.085381,"median":-3.51872,"eighty":-0.854355,"marketCap":207520115},{"date":"2023-06-02","current":-2.396553,"twenty":-9.085381,"median":-3.51872,"eighty":-0.858045,"marketCap":204562584},{"date":"2023-06-09","current":-2.361904,"twenty":-9.085381,"median":-3.51872,"eighty":-0.86619,"marketCap":201605053},{"date":"2023-06-16","current":-2.361904,"twenty":-9.085381,"median":-3.51872,"eighty":-0.879261,"marketCap":201605053},{"date":"2023-06-23","current":-2.402328,"twenty":-9.087797,"median":-3.53284,"eighty":-0.88307,"marketCap":205055506},{"date":"2023-06-30","current":-2.021189,"twenty":-9.090214,"median":-3.532909,"eighty":-0.895974,"marketCap":172522661},{"date":"2023-07-07","current":-1.940342,"twenty":-9.090214,"median":-3.532909,"eighty":-0.899395,"marketCap":165621755},{"date":"2023-07-14","current":-1.957666,"twenty":-9.090214,"median":-3.532909,"eighty":-0.906287,"marketCap":167100520},{"date":"2023-07-21","current":-1.836395,"twenty":-9.090214,"median":-3.532909,"eighty":-0.909901,"marketCap":156749161},{"date":"2023-07-28","current":-1.726673,"twenty":-9.090214,"median":-3.532909,"eighty":-0.919185,"marketCap":147383645},{"date":"2023-08-04","current":-1.795971,"twenty":-9.090214,"median":-3.532909,"eighty":-0.928329,"marketCap":153298707},{"date":"2023-08-11","current":-1.969804,"twenty":-9.090214,"median":-3.532909,"eighty":-0.937755,"marketCap":160166735},{"date":"2023-08-18","current":-1.743017,"twenty":-9.090214,"median":-3.532909,"eighty":-0.941735,"marketCap":141726485},{"date":"2023-08-25","current":-1.587507,"twenty":-9.090214,"median":-3.532909,"eighty":-0.945086,"marketCap":129081743},{"date":"2023-09-01","current":-1.639343,"twenty":-9.090214,"median":-3.532909,"eighty":-0.956324,"marketCap":133296657},{"date":"2023-09-08","current":-1.593986,"twenty":-9.090214,"median":-3.532909,"eighty":-0.958492,"marketCap":129608607},{"date":"2023-09-15","current":-1.807814,"twenty":-9.090214,"median":-3.532909,"eighty":-0.970251,"marketCap":146995128},{"date":"2023-09-22","current":-1.658782,"twenty":-9.090214,"median":-3.532909,"eighty":-0.979536,"marketCap":134877250},{"date":"2023-09-29","current":-1.619905,"twenty":-9.090214,"median":-3.532909,"eighty":-0.985303,"marketCap":131716065},{"date":"2023-10-06","current":-1.684701,"twenty":-9.090214,"median":-3.532909,"eighty":-0.991188,"marketCap":136984707},{"date":"2023-10-13","current":-1.69118,"twenty":-9.090214,"median":-3.532909,"eighty":-1.00206,"marketCap":137511571},{"date":"2023-10-20","current":-1.509751,"twenty":-9.090214,"median":-3.532909,"eighty":-1.006093,"marketCap":122759372},{"date":"2023-10-27","current":-1.503271,"twenty":-9.120812,"median":-3.537707,"eighty":-1.019689,"marketCap":122232508},{"date":"2023-11-03","current":-1.658782,"twenty":-9.120812,"median":-3.537707,"eighty":-1.028451,"marketCap":134877250},{"date":"2023-11-10","current":-1.677615,"twenty":-9.120812,"median":-3.537707,"eighty":-1.034911,"marketCap":131635733},{"date":"2023-11-17","current":-1.615988,"twenty":-9.120812,"median":-3.537707,"eighty":-1.035705,"marketCap":126800135},{"date":"2023-11-24","current":-1.924122,"twenty":-9.120812,"median":-3.537707,"eighty":-1.035705,"marketCap":150978127},{"date":"2023-12-01","current":-2.163781,"twenty":-9.120812,"median":-3.537707,"eighty":-1.035705,"marketCap":169783232},{"date":"2023-12-08","current":-4.505594,"twenty":-9.110613,"median":-3.544802,"eighty":-1.035771,"marketCap":353535971},{"date":"2023-12-15","current":-4.793186,"twenty":-9.110613,"median":-3.60865,"eighty":-1.041865,"marketCap":376102097},{"date":"2023-12-22","current":-5.402605,"twenty":-9.110613,"median":-3.686688,"eighty":-1.046438,"marketCap":423920792},{"date":"2023-12-29","current":-7.956688,"twenty":-9.120812,"median":-3.745808,"eighty":-1.059015,"marketCap":624329481},{"date":"2024-01-05","current":-8.00462,"twenty":-9.131012,"median":-3.795468,"eighty":-1.062066,"marketCap":628090501},{"date":"2024-01-12","current":-7.867672,"twenty":-9.131012,"median":-3.884844,"eighty":-1.073911,"marketCap":617344727},{"date":"2024-01-19","current":-7.388353,"twenty":-9.141211,"median":-4.008415,"eighty":-1.078488,"marketCap":579734518},{"date":"2024-01-26","current":-6.354395,"twenty":-9.131012,"median":-4.119442,"eighty":-1.078619,"marketCap":498603922},{"date":"2024-02-02","current":-6.765239,"twenty":-9.131012,"median":-4.20221,"eighty":-1.078619,"marketCap":530841245},{"date":"2024-02-09","current":-6.635138,"twenty":-9.131012,"median":-4.339366,"eighty":-1.078619,"marketCap":520632759},{"date":"2024-02-16","current":-6.12843,"twenty":-9.131012,"median":-4.37682,"eighty":-1.078619,"marketCap":480873395},{"date":"2024-02-23","current":-6.073651,"twenty":-9.131012,"median":-4.459875,"eighty":-1.082595,"marketCap":476575085},{"date":"2024-03-01","current":-8.285364,"twenty":-9.152685,"median":-4.505594,"eighty":-1.101931,"marketCap":650119339},{"date":"2024-03-08","current":-6.86795,"twenty":-9.152685,"median":-4.658612,"eighty":-1.122353,"marketCap":538900576},{"date":"2024-03-15","current":-6.864526,"twenty":-9.152685,"median":-4.78631,"eighty":-1.163594,"marketCap":538631931},{"date":"2024-03-22","current":-6.237989,"twenty":-9.152685,"median":-4.819439,"eighty":-1.201744,"marketCap":489470014},{"date":"2024-03-28","current":-7.125839,"twenty":-9.152685,"median":-4.887378,"eighty":-1.371955,"marketCap":630259092},{"date":"2024-04-05","current":-7.133855,"twenty":-9.15651,"median":-4.944847,"eighty":-1.549925,"marketCap":630968045},{"date":"2024-04-12","current":-6.733076,"twenty":-9.15651,"median":-4.976853,"eighty":-1.582323,"marketCap":595520402},{"date":"2024-04-19","current":-5.522726,"twenty":-9.15651,"median":-5.010669,"eighty":-1.603058,"marketCap":488468520},{"date":"2024-04-26","current":-5.771208,"twenty":-9.152685,"median":-5.065719,"eighty":-1.622497,"marketCap":510446059},{"date":"2024-05-03","current":-5.763193,"twenty":-9.152685,"median":-5.137904,"eighty":-1.632864,"marketCap":509737106},{"date":"2024-05-10","current":-5.900173,"twenty":-9.152685,"median":-5.17612,"eighty":-1.651056,"marketCap":547341314},{"date":"2024-05-17","current":-6.802306,"twenty":-9.152685,"median":-5.23434,"eighty":-1.663576,"marketCap":631029499},{"date":"2024-05-24","current":-5.648207,"twenty":-9.152685,"median":-5.250196,"eighty":-1.680449,"marketCap":523967191},{"date":"2024-05-31","current":-5.365414,"twenty":-9.152685,"median":-5.252552,"eighty":-1.69118,"marketCap":497733380},{"date":"2024-06-07","current":-5.143766,"twenty":-9.152685,"median":-5.262603,"eighty":-1.719691,"marketCap":477171745},{"date":"2024-06-14","current":-5.05205,"twenty":-9.15651,"median":-5.263947,"eighty":-1.733603,"marketCap":468663482},{"date":"2024-06-21","current":-4.539966,"twenty":-9.160335,"median":-5.26529,"eighty":-1.749497,"marketCap":421159014},{"date":"2024-06-28","current":-4.880081,"twenty":-9.164959,"median":-5.282272,"eighty":-1.761776,"marketCap":452710489},{"date":"2024-07-05","current":-5.044407,"twenty":-9.164959,"median":-5.287002,"eighty":-1.782905,"marketCap":467954460},{"date":"2024-07-12","current":-5.869855,"twenty":-9.164959,"median":-5.307752,"eighty":-1.813296,"marketCap":544528826},{"date":"2024-07-15","current":-6.038002,"twenty":-9.164959,"median":-5.325968,"eighty":-1.814927,"marketCap":560127308},{"date":"2024-08-02","current":-4.654611,"twenty":-9.22331,"median":-5.382384,"eighty":-1.858355,"marketCap":431794343},{"date":"2024-08-09","current":-4.4375,"twenty":-9.22331,"median":-5.382384,"eighty":-1.898763,"marketCap":449722870},{"date":"2024-08-16","current":-4.375927,"twenty":-9.22331,"median":-5.382384,"eighty":-1.922746,"marketCap":443482734},{"date":"2024-08-23","current":-4.740588,"twenty":-9.22331,"median":-5.382384,"eighty":-1.94836,"marketCap":480439628},{"date":"2024-08-30","current":-4.635397,"twenty":-9.22331,"median":-5.382384,"eighty":-1.963276,"marketCap":469778986},{"date":"2024-09-06","current":-4.481118,"twenty":-9.22331,"median":-5.382384,"eighty":-1.992315,"marketCap":454143376},{"date":"2024-09-13","current":-4.97902,"twenty":-9.22331,"median":-5.382384,"eighty":-2.006297,"marketCap":504603752},{"date":"2024-09-20","current":-5.308617,"twenty":-9.22331,"median":-5.392613,"eighty":-2.04582,"marketCap":538007099},{"date":"2024-09-27","current":-4.775651,"twenty":-9.22331,"median":-5.402605,"eighty":-2.071356,"marketCap":483993176},{"date":"2024-10-04","current":-4.312813,"twenty":-9.22331,"median":-5.402605,"eighty":-2.098777,"marketCap":437086348},{"date":"2024-10-11","current":-4.221648,"twenty":-9.22331,"median":-5.402605,"eighty":-2.13584,"marketCap":427847125},{"date":"2024-10-18","current":-4.761626,"twenty":-9.22331,"median":-5.402605,"eighty":-2.165516,"marketCap":482571757},{"date":"2024-10-25","current":-4.744094,"twenty":-9.22331,"median":-5.402605,"eighty":-2.226131,"marketCap":480794983},{"date":"2024-10-31","current":-4.740588,"twenty":-9.22331,"median":-5.402605,"eighty":-2.244588,"marketCap":480439628},{"date":"2024-11-08","current":-5.231477,"twenty":-9.225312,"median":-5.405129,"eighty":-2.271833,"marketCap":530189294},{"date":"2024-11-15","current":-5.809106,"twenty":-9.225312,"median":-5.445898,"eighty":-2.292553,"marketCap":601358704},{"date":"2024-11-22","current":-5.774753,"twenty":-9.225312,"median":-5.463564,"eighty":-2.309931,"marketCap":597802473},{"date":"2024-11-29","current":-5.888119,"twenty":-9.225312,"median":-5.498958,"eighty":-2.31901,"marketCap":609538036},{"date":"2024-12-06","current":-6.279744,"twenty":-9.225312,"median":-5.534802,"eighty":-2.33289,"marketCap":650079072},{"date":"2024-12-13","current":-5.90186,"twenty":-9.225312,"median":-5.583452,"eighty":-2.353729,"marketCap":610960528},{"date":"2024-12-20","current":-5.620165,"twenty":-9.225312,"median":-5.617263,"eighty":-2.367082,"marketCap":581799432},{"date":"2024-12-27","current":-5.496493,"twenty":-9.225312,"median":-5.622268,"eighty":-2.3962,"marketCap":568997000},{"date":"2025-01-03","current":-4.885009,"twenty":-9.225312,"median":-5.622268,"eighty":-2.406198,"marketCap":505696083},{"date":"2025-01-10","current":-5.11861,"twenty":-9.227313,"median":-5.624371,"eighty":-2.432957,"marketCap":529878456},{"date":"2025-01-17","current":-4.610184,"twenty":-9.227313,"median":-5.624371,"eighty":-2.450298,"marketCap":477246233},{"date":"2025-01-24","current":-4.850655,"twenty":-9.227313,"median":-5.624371,"eighty":-2.462386,"marketCap":502139852},{"date":"2025-01-31","current":-4.809432,"twenty":-9.227313,"median":-5.624371,"eighty":-2.492163,"marketCap":497872375},{"date":"2025-02-07","current":-4.747596,"twenty":-9.227313,"median":-5.624371,"eighty":-2.545445,"marketCap":491471158},{"date":"2025-02-14","current":-4.280394,"twenty":-9.227313,"median":-5.624371,"eighty":-2.577061,"marketCap":443106413},{"date":"2025-02-21","current":-4.555219,"twenty":-9.227313,"median":-5.624371,"eighty":-2.609749,"marketCap":471556263},{"date":"2025-02-28","current":-4.886485,"twenty":-9.227313,"median":-5.624371,"eighty":-2.682852,"marketCap":464504340},{"date":"2025-03-07","current":-4.528833,"twenty":-9.229315,"median":-5.62647,"eighty":-2.751011,"marketCap":430506348},{"date":"2025-03-14","current":-4.212868,"twenty":-9.229315,"median":-5.62647,"eighty":-2.800801,"marketCap":400471021},{"date":"2025-03-21","current":-4.682765,"twenty":-9.229315,"median":-5.62647,"eighty":-2.864367,"marketCap":445138943},{"date":"2025-03-28","current":-4.51263,"twenty":-9.229315,"median":-5.62647,"eighty":-2.887636,"marketCap":428966075},{"date":"2025-04-04","current":-3.613344,"twenty":-9.229315,"median":-5.62647,"eighty":-2.950267,"marketCap":343480914},{"date":"2025-04-11","current":-3.370294,"twenty":-9.227313,"median":-5.624371,"eighty":-3.036633,"marketCap":320376817},{"date":"2025-04-17","current":-3.564734,"twenty":-9.227313,"median":-5.624371,"eighty":-3.077604,"marketCap":338860095},{"date":"2025-04-25","current":-4.188563,"twenty":-9.229315,"median":-5.62647,"eighty":-3.116395,"marketCap":398160611},{"date":"2025-05-02","current":-4.188563,"twenty":-9.229315,"median":-5.62647,"eighty":-3.213748,"marketCap":398160611},{"date":"2025-05-09","current":-4.698968,"twenty":-9.229315,"median":-5.62647,"eighty":-3.305959,"marketCap":446679216},{"date":"2025-05-16","current":-5.195017,"twenty":-9.229315,"median":-5.62647,"eighty":-3.335282,"marketCap":468798303},{"date":"2025-05-23","current":-5.186029,"twenty":-9.229315,"median":-5.62647,"eighty":-3.341904,"marketCap":467987234},{"date":"2025-05-30","current":-5.042222,"twenty":-9.229315,"median":-5.61173,"eighty":-3.341904,"marketCap":455010118},{"date":"2025-06-06","current":-4.907403,"twenty":-9.1665,"median":-5.562525,"eighty":-3.341904,"marketCap":442844072},{"date":"2025-06-13","current":-6.426361,"twenty":-9.1665,"median":-5.534802,"eighty":-3.341904,"marketCap":579914856},{"date":"2025-06-20","current":-6.093808,"twenty":-9.168041,"median":-5.530847,"eighty":-3.339066,"marketCap":549905276},{"date":"2025-06-27","current":-3.244638,"twenty":-9.078131,"median":-5.526011,"eighty":-3.334336,"marketCap":292796172},{"date":"2025-07-03","current":-4.278249,"twenty":-8.981846,"median":-5.496493,"eighty":-3.33323,"marketCap":386069191},{"date":"2025-07-11","current":-3.954684,"twenty":-8.930849,"median":-5.462896,"eighty":-3.33323,"marketCap":356870681},{"date":"2025-07-18","current":-3.640107,"twenty":-8.858572,"median":-5.407653,"eighty":-3.33323,"marketCap":328483240},{"date":"2025-07-25","current":-3.694034,"twenty":-8.833277,"median":-5.382384,"eighty":-3.33323,"marketCap":333349659},{"date":"2025-08-01","current":-3.316542,"twenty":-8.74252,"median":-5.347811,"eighty":-3.316542,"marketCap":299284730},{"date":"2025-08-08","current":-3.163747,"twenty":-8.648531,"median":-5.308617,"eighty":-3.29177,"marketCap":285496544},{"date":"2025-08-15","current":-3.701442,"twenty":-8.585874,"median":-5.28636,"eighty":-3.28059,"marketCap":324786691},{"date":"2025-08-22","current":-3.550568,"twenty":-8.510418,"median":-5.26529,"eighty":-3.28059,"marketCap":311548103},{"date":"2025-08-29","current":-3.731616,"twenty":-8.456341,"median":-5.254536,"eighty":-3.28059,"marketCap":327434408},{"date":"2025-09-05","current":-3.580742,"twenty":-8.309672,"median":-5.247127,"eighty":-3.279988,"marketCap":314195820},{"date":"2025-09-12","current":-3.7115,"twenty":-8.255139,"median":-5.235483,"eighty":-3.28059,"marketCap":325669263},{"date":"2025-09-19","current":-3.892549,"twenty":-8.21689,"median":-5.210439,"eighty":-3.28059,"marketCap":341555569},{"date":"2025-09-26","current":-3.94284,"twenty":-8.111531,"median":-5.187316,"eighty":-3.28059,"marketCap":345968431},{"date":"2025-10-03","current":-3.952898,"twenty":-8.025162,"median":-5.164674,"eighty":-3.28059,"marketCap":346851004},{"date":"2025-10-10","current":-4.023306,"twenty":-7.942782,"median":-5.143766,"eighty":-3.28059,"marketCap":353029012},{"date":"2025-10-17","current":-3.912665,"twenty":-7.862815,"median":-5.126287,"eighty":-3.28059,"marketCap":343320714},{"date":"2025-10-24","current":-3.983073,"twenty":-7.799198,"median":-5.099688,"eighty":-3.28059,"marketCap":349498721},{"date":"2025-10-31","current":-4.093714,"twenty":-7.710945,"median":-5.053881,"eighty":-3.28059,"marketCap":359207019},{"date":"2025-11-07","current":-4.143879,"twenty":-7.648555,"median":-5.044407,"eighty":-3.28059,"marketCap":347733576},{"date":"2025-11-14","current":-5.044056,"twenty":-7.566386,"median":-5.044056,"eighty":-3.28059,"marketCap":423271942},{"date":"2025-11-21","current":-5.55813,"twenty":-7.566386,"median":-5.044056,"eighty":-3.28059,"marketCap":466410460},{"date":"2025-11-28","current":-6.540439,"twenty":-7.511606,"median":-5.044056,"eighty":-3.28059,"marketCap":548840945},{"date":"2025-12-05","current":-6.602611,"twenty":-7.446462,"median":-5.044056,"eighty":-3.28059,"marketCap":554058064},{"date":"2025-12-12","current":-6.639913,"twenty":-7.388353,"median":-5.044056,"eighty":-3.28059,"marketCap":557188335},{"date":"2025-12-19","current":-6.279319,"twenty":-7.280593,"median":-5.044056,"eighty":-3.28059,"marketCap":526929044},{"date":"2025-12-26","current":-4.948849,"twenty":-7.205023,"median":-5.042222,"eighty":-3.28059,"marketCap":415282692},{"date":"2026-01-02","current":-4.48878,"twenty":-7.158501,"median":-5.023558,"eighty":-3.28059,"marketCap":376676009},{"date":"2026-01-09","current":-5.307185,"twenty":-7.114457,"median":-5.022421,"eighty":-3.28059,"marketCap":445352424},{"date":"2026-01-16","current":-5.51531,"twenty":-7.007306,"median":-5.022421,"eighty":-3.28059,"marketCap":462817225},{"date":"2026-01-23","current":-6.9982,"twenty":-6.984046,"median":-5.022421,"eighty":-3.28059,"marketCap":587253932},{"date":"2026-01-30","current":-6.633981,"twenty":-6.949155,"median":-5.022421,"eighty":-3.28059,"marketCap":556690530},{"date":"2026-02-06","current":-7.342419,"twenty":-6.949155,"median":-5.022421,"eighty":-3.28059,"marketCap":616139063},{"date":"2026-02-13","current":-6.820092,"twenty":-6.936424,"median":-5.022421,"eighty":-3.28059,"marketCap":572308032},{"date":"2026-02-20","current":-6.700703,"twenty":-6.909634,"median":-5.022421,"eighty":-3.28059,"marketCap":562289511},{"date":"2026-02-27","current":-6.655932,"twenty":-6.86795,"median":-5.022421,"eighty":-3.28059,"marketCap":558532565},{"date":"2026-03-06","current":-4.982649,"twenty":-6.839679,"median":-5.015258,"eighty":-3.28059,"marketCap":438936467},{"date":"2026-03-13","current":-5.315427,"twenty":-6.799476,"median":-5.015258,"eighty":-3.28059,"marketCap":468251938},{"date":"2026-03-20","current":-5.051022,"twenty":-6.771856,"median":-5.015258,"eighty":-3.28059,"marketCap":444959705},{"date":"2026-03-27","current":-4.726103,"twenty":-6.758392,"median":-4.993045,"eighty":-3.28059,"marketCap":416336566},{"date":"2026-04-02","current":-4.60795,"twenty":-6.742082,"median":-4.985041,"eighty":-3.28059,"marketCap":405928152},{"date":"2026-04-10","current":-4.991946,"twenty":-6.724631,"median":-4.97902,"eighty":-3.28059,"marketCap":439755498},{"date":"2026-04-17","current":-5.183944,"twenty":-6.698372,"median":-4.968056,"eighty":-3.28059,"marketCap":456669171},{"date":"2026-04-24","current":-4.268262,"twenty":-6.667857,"median":-4.968056,"eighty":-3.28059,"marketCap":376003961},{"date":"2026-05-01","current":-5.731651,"twenty":-6.635138,"median":-4.968056,"eighty":-3.28059,"marketCap":504918330},{"date":"2026-05-08","current":-6.701623,"twenty":-6.633981,"median":-4.968056,"eighty":-3.28059,"marketCap":590366048},{"date":"2026-05-15","current":-6.23472,"twenty":-6.623275,"median":-4.968056,"eighty":-3.28059,"marketCap":567864529},{"date":"2026-05-22","current":-6.256072,"twenty":-6.576982,"median":-4.968056,"eighty":-3.28059,"marketCap":569809271},{"date":"2026-05-29","current":-6.554997,"twenty":-6.563229,"median":-4.964679,"eighty":-3.279988,"marketCap":597035652},{"date":"2026-06-05","current":-6.23472,"twenty":-6.540827,"median":-4.968056,"eighty":-3.28059,"marketCap":567864529},{"date":"2026-06-12","current":-5.530111,"twenty":-6.520195,"median":-4.968056,"eighty":-3.28059,"marketCap":503688058},{"date":"2026-06-18","current":-5.63687,"twenty":-6.512293,"median":-4.968056,"eighty":-3.28059,"marketCap":513411766},{"date":"2026-06-26","current":-6.127961,"twenty":-6.456353,"median":-4.964679,"eighty":-3.279988,"marketCap":558140821},{"date":"2026-07-02","current":-6.725811,"twenty":-6.456353,"median":-4.964679,"eighty":-3.279988,"marketCap":612593585},{"date":"2026-07-10","current":-6.661756,"twenty":-6.485149,"median":-4.964679,"eighty":-3.279988,"marketCap":606759360},{"date":"2026-07-17","current":-6.085257,"twenty":-6.489568,"median":-4.964679,"eighty":-3.279988,"marketCap":554251338},{"date":"2026-07-24","current":-6.063906,"twenty":-6.489568,"median":-4.964679,"eighty":-3.279988,"marketCap":552306597},{"date":"2026-07-31","current":-6.362831,"twenty":-6.489911,"median":-4.961303,"eighty":-3.279387,"marketCap":579532978},{"date":"2026-08-07","current":-6.426886,"twenty":-6.486168,"median":-4.961303,"eighty":-3.279387,"marketCap":585367203},{"date":"2026-08-14","current":-6.105176,"twenty":-6.475406,"median":-4.961303,"eighty":-3.279387,"marketCap":560210978},{"date":"2026-08-21","current":-6.253566,"twenty":-6.456483,"median":-4.961303,"eighty":-3.279387,"marketCap":573827217}],"updateTime":1787434454168},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALT\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2645042865","title":"U.S. RESEARCH ROUNDUP-Baldwin Insurance Group, Diamondback Energy, Visteon","url":"https://stock-news.laohu8.com/highlight/detail?id=2645042865","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645042865?lang=en_us&edition=fundamental","pubTime":"2026-06-22 15:47","pubTimestamp":1782114448,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Baldwin Insurance Group, Diamondback Energy, VisteonJune 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nL4N42U0H9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","ALGM","LQDA","GLW","KR","INTW","MRNX","LRCU","VC","DAL","MULL","FANG","INCY","BYD","KLAG","CNXU","AMAT","MTDR","MRNY","ARMK","MU","DFTX","NBIX","ALT","FTH","LGN","BILL","CHRD","FMC","LRCX","KLAC","DCH","ABVX","LINT","AGMB","MRK","BWIN","HCA","KMX","BWXT","AMRZ","APGE","INTC","AALG","FPS","AAL","MUU","DAR","ENPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644767783","title":"Altimmune plans to move headquarters to Morristown, New Jersey from Maryland","url":"https://stock-news.laohu8.com/highlight/detail?id=2644767783","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644767783?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:08","pubTimestamp":1781640486,"startTime":"0","endTime":"0","summary":"Altimmune plans to relocate its corporate headquarters to Morristown, New Jersey from Gaithersburg, Maryland later this year.Signed a five-year office lease for the new site with annual rent of about $300,000.Move targets improved talent access in a major biopharma hub, supporting its hybrid model.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Altimmune Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 16, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL8r9ZRj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1878469433.USD","ALT","BK4139","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642282822","title":"Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2642282822","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642282822?lang=en_us&edition=fundamental","pubTime":"2026-06-11 20:00","pubTimestamp":1781179200,"startTime":"0","endTime":"0","summary":"-- Single dose of CB-011 produced deep, durable responses in heavily pretreated, BCMA-nave patients with r/r MM: 83% CR rate, 91% MRD negativity, and 50% of patients in ≥CR at 15 months -- -- Case stu","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/11/3310377/0/en/Caribou-Biosciences-Reports-Dose-Escalation-Durability-Data-for-CB-011-at-the-2026-European-Hematology-Association-EHA-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4230","LD","IE0031619046.USD","LU0314106906.USD","ORR","BK4585","EPV","CRS","BK4599","LU0256863811.USD","LU0868494617.USD","LU0963586101.USD","BK4187","BK4107","IE00B66KJ199.SGD","LU1506573853.SGD","LU1878469433.USD","BK4588","BK4139","BK4006","IE00B7SZL793.SGD","BK4539","CAR","ALT","LU2065731478.USD","CRBU","BK4022","LU0417517546.SGD","IE00B19Z4B17.USD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641796861","title":"Boehringer - 84.2% Patients on Survodutide Cut Liver Fat by at Least 30% VS 24.3% on Placebo in Synchronize-Masld","url":"https://stock-news.laohu8.com/highlight/detail?id=2641796861","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641796861?lang=en_us&edition=fundamental","pubTime":"2026-06-08 02:30","pubTimestamp":1780857001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260607:nL4N42D181:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999015952.SGD","SG9999014906.USD","LU1023059063.AUD","SG9999014880.SGD","SG9999001176.SGD","SG9999015945.SGD","LU0122379950.USD","LU2237443382.USD","LU1629891620.HKD","IE00B4R5TH58.HKD","LU2750360997.AUD","IE00BFSS7M15.SGD","IE0001KFT4U8.USD","LU0820561818.USD","LU0353189680.USD","LU0882574055.USD","LLII","LU2602419157.SGD","SGXZ99366536.SGD","LU0882574139.USD","LU1291159041.SGD","LU2265009873.SGD","LU2461242641.AUD","LU1868836591.USD","BK4585","LU2111349929.HKD","LU2360106947.USD","IE00B7KXQ091.USD","LU2552382215.SGD","IE0009355771.USD","LU0289739699.SGD","LU2106854487.HKD","LU2168564149.EUR","LU2361044865.SGD","IE00BWXC8680.SGD","LU2361045086.USD","SGXZ51526630.SGD","LU0823416689.USD","GB00BDT5M118.USD","LU0203202063.USD","LU0471298694.HKD","LU2089984988.USD","LU0787776722.HKD","LU0417517546.SGD","LU1061106388.HKD","LU1035775433.USD","SG9999018857.SGD","IE00BFTCPJ56.SGD","LU2237443549.SGD","ELIL","LU2237443465.HKD","LU2236285917.USD","LU0320765992.SGD","LU2324357040.USD","LLY","LU0640476718.USD","LU0456855351.SGD","IE00BKDWB100.SGD","LLYX","LU1323610961.USD","BK4516","LU0058720904.USD","LU2471134796.USD","IE00B1XK9C88.USD","LU1868837136.USD","LU0320765059.SGD","LU1551013425.SGD","LU0672654240.SGD","IE00B775H168.HKD","LU2168564495.EUR","LU1917777945.USD","LU0689472784.USD","LU1127390331.HKD","LU1712237335.SGD","LU2108987350.USD","LU0466842654.USD","LU0061475181.USD","LU2750360641.GBP","LU0158827781.USD","LU0820561909.HKD","ALT","LU0820562030.AUD","LU0889565916.HKD","LU1267930730.SGD","LU1280957306.USD","LU2271345857.HKD","BK4533","LU0266013472.USD","SG9999014914.USD","IE00BJJMRZ35.SGD","LU0097036916.USD","LU1623119135.USD","BK4007","LU2756315318.SGD","LU2023251221.USD","LU0964807845.USD","LU1064131342.USD","LU0114720955.EUR","IE00BJJMRX11.SGD","LU1145028129.USD","LU1868836914.USD","SGXZ57979304.SGD","LLYZ","LU2237438978.USD","IE00BJLML261.HKD","IE00BJT1NW94.SGD","LU2756315664.SGD","IE00BFSS8Q28.SGD","LU1989771016.USD","LU0109391861.USD","LU2491049909.HKD","ELIS","LU0203201768.USD","LU1983299246.USD","LU0238689110.USD","LU1988902786.USD","LU2456880835.USD","LU1974910355.USD","LU2896262040.SGD","BK4534","LU0943347566.SGD","LU1804176565.USD","LU0385154629.USD","LU2237443895.HKD","LU1868837300.USD","LU2491050071.SGD","SG9999015986.USD","LU2357305700.SGD","LU2361044949.HKD","LU0096364046.USD","LU1720051017.SGD","LU2213496289.HKD","LU2168564065.EUR","LU2028103732.USD","LU0471298777.SGD","LU0198837287.USD","LU2746668974.SGD","IE00BK4W5M84.HKD","LU0006306889.USD","LU0133085943.USD","LU0353189763.USD","LU2746668461.USD","LU1057294990.SGD","LU1548497426.USD","LU0234572021.USD","IE0005OL40V9.USD","LU1093756168.USD","LU0432979614.USD","LU2471134879.HKD","LU1878469433.USD","IE00BK4W5L77.USD","LU2063271972.USD","LU1720051108.HKD","LU2168563687.JPY","LU2087625088.SGD","SG9999013999.USD","BK4139","BK4581","IE00B1BXHZ80.USD","LU1366192091.USD","LU0256863811.USD","LU2112291526.USD","LU2237443622.USD","LU2023250504.SGD","IE00B2B36J28.USD","LU0109394709.USD","LU0158827948.USD","LU0683600562.USD","LU0354030438.USD","LU1868836757.USD","LU2089283258.USD","LU0316494557.USD","SG9999001176.USD","IE00BN29S564.USD","LU2491050154.USD","LU2417539215.USD","SG9999017495.SGD","IE0002141913.USD","IE00BJJMRY28.SGD","LU0708995401.HKD","SG9999014898.SGD","LU1551013342.USD","IE00BKPKM429.USD","BK4599","LU2211815571.USD","LU2264538146.SGD","LU2468319806.SGD","LU2552382058.USD","LU2471134952.CNY","LU2552382132.HKD","LU0786609619.USD","LU2462157665.USD","BK4588","LU1069344957.HKD","LU0823434583.USD","SG9999015978.USD","SG9999018865.SGD","LU0354030511.USD","LU2023250330.USD","IE00B4JS1V06.HKD","SGXZ81514606.USD","LU0256863902.USD","SGXZ31699556.SGD","IE0004445239.USD","LU0094547139.USD","LU0823434740.USD","IE0004445015.USD","LU0106261372.USD","LU1093756325.SGD","LU1232071149.USD","LU1814569148.SGD","LU2089284900.SGD","LU2237443978.SGD","LU2471134523.USD","LU2168564222.USD","LU0323591593.USD","LU0210536198.USD","LU0079474960.USD","LU0225283273.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641681179","title":"Boehringer-Zealand's obesity drug shows promise in cutting visceral, liver fat","url":"https://stock-news.laohu8.com/highlight/detail?id=2641681179","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641681179?lang=en_us&edition=fundamental","pubTime":"2026-06-08 02:30","pubTimestamp":1780857001,"startTime":"0","endTime":"0","summary":"Boehringer-Zealand's obesity drug shows promise in cutting visceral, liver fatBoehringer's injectable drug helps preserve lean mass while reducing abdominal fat Patients with fatty liver disease also show benefitAnalysts see benefits beyond weight loss percentage as key for commercial successBy Bhanvi Satija. In a separate late-stage study of overweight or obese patients with a fatty liver disease called MASLD, survodutide met both its main goals.  After 48 weeks, up to 84.2% of patients on the drug showed a liver fat reduction of at least 30%, compared with 24.3% for those on placebo. Patients on survodutide also lost up to 12.2% of their body weight, versus 1% for placebo.In 61% of the patients the drug helped achieve liver fat normalization, or a liver fat content below 5%, compared with 5.7% on placebo.     U.S. biotech Altimmune ALT.O is also developing a drug that targets both the appetite-suppressing gut hormone, GLP-1, and gluca","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260607:nL4N42D181:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ81514606.USD","ELIL","ELIS","LU1291159041.SGD","LU2063271972.USD","LU1093756168.USD","LU2462157665.USD","ALT","BK4007","LU0109394709.USD","BK4139","LU2357305700.SGD","SG9999018857.SGD","LU2106854487.HKD","LU2108987350.USD","LLII","LU1280957306.USD","LU2756315664.SGD","LU0320765059.SGD","LU0417517546.SGD","BK4516","LU0210536198.USD","LU2237443622.USD","LLY","LU0320765992.SGD","LU0256863902.USD","LU2028103732.USD","LU2168564149.EUR","SG9999014914.USD","IE00BJJMRY28.SGD","BK4533","SGXZ51526630.SGD","LU2265009873.SGD","LU2111349929.HKD","IE00B7KXQ091.USD","LU1057294990.SGD","IE0009355771.USD","LU1232071149.USD","LU0882574139.USD","LU1023059063.AUD","LLYX","LU0882574055.USD","LU2237443382.USD","SGXZ57979304.SGD","IE0004445239.USD","LU0353189763.USD","LU0964807845.USD","LLYZ","SG9999014898.SGD","SG9999015978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641179572","title":"Boehringer - Survodutide Drug Showed 34% Visceral and 63% Liver Fat Reduction, Minimized Lean Mass Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2641179572","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641179572?lang=en_us&edition=fundamental","pubTime":"2026-06-08 02:30","pubTimestamp":1780857001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260607:nL4N42D181:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1023059063.AUD","LU0238689110.USD","SG9999014906.USD","LU0823416689.USD","IE00B1XK9C88.USD","LLYZ","LU2265009873.SGD","LU2491050071.SGD","LU2756315318.SGD","IE00BJJMRZ35.SGD","LU1280957306.USD","LU1988902786.USD","LU0256863902.USD","LU1551013425.SGD","LU1629891620.HKD","LU2462157665.USD","LU2168564149.EUR","LU2271345857.HKD","BK4585","LU2023250330.USD","LU1720051017.SGD","LU2491049909.HKD","LU1974910355.USD","LU1093756325.SGD","LU0079474960.USD","IE0001KFT4U8.USD","LU2108987350.USD","LU0266013472.USD","LU1868837136.USD","LU1551013342.USD","LU2237443622.USD","ELIS","LU2324357040.USD","LU0786609619.USD","LU1064131342.USD","SG9999015945.SGD","LU0882574139.USD","LU2089984988.USD","LU2746668461.USD","LU2552382215.SGD","IE0004445015.USD","LU2168564065.EUR","LU2750360997.AUD","LU2237443382.USD","LU1868836757.USD","LU2023250504.SGD","LU0061475181.USD","LU0096364046.USD","LU0106261372.USD","LU0471298777.SGD","LU0234572021.USD","SGXZ81514606.USD","LU2456880835.USD","LU2602419157.SGD","LU2237443465.HKD","SG9999013999.USD","LU2211815571.USD","BK4533","LU0323591593.USD","LU2361044949.HKD","BK4516","LU1145028129.USD","LU0109394709.USD","LU1989771016.USD","LU2461242641.AUD","IE00BJJMRX11.SGD","IE00B775H168.HKD","SG9999001176.USD","BK4007","SG9999014898.SGD","LU0820562030.AUD","LU0672654240.SGD","LU1712237335.SGD","LU0133085943.USD","LU2089283258.USD","SG9999015978.USD","LU2471134796.USD","IE00BJT1NW94.SGD","LU0320765992.SGD","SG9999018865.SGD","IE0002141913.USD","LU0203201768.USD","LU0882574055.USD","LU1983299246.USD","LU0417517546.SGD","LU2106854487.HKD","SGXZ99366536.SGD","LU1267930730.SGD","LU1366192091.USD","LU0320765059.SGD","LU2237443978.SGD","LU0823434740.USD","LU0109391861.USD","LU2552382058.USD","IE00BWXC8680.SGD","LU2237443895.HKD","IE0009355771.USD","LU0210536198.USD","IE0005OL40V9.USD","LU0823434583.USD","LU2089284900.SGD","LU0354030511.USD","LU2746668974.SGD","LU2468319806.SGD","LU0094547139.USD","LU0353189763.USD","LU1878469433.USD","LU2361045086.USD","LU2471134952.CNY","IE00BKDWB100.SGD","LU0114720955.EUR","SG9999017495.SGD","LU1720051108.HKD","ELIL","LU0787776722.HKD","LU0385154629.USD","SGXZ51526630.SGD","LU0225283273.USD","IE00BKPKM429.USD","IE00BK4W5M84.HKD","ALT","LU0964807845.USD","LU0708995401.HKD","LU0820561818.USD","LU2471134879.HKD","LU2063271972.USD","LU2417539215.USD","SGXZ31699556.SGD","LU1069344957.HKD","BK4588","LU2213496289.HKD","SGXZ57979304.SGD","LU1868837300.USD","LU0943347566.SGD","LU0353189680.USD","LU1814569148.SGD","SG9999014880.SGD","LU2360106947.USD","IE00BFSS7M15.SGD","LU0889565916.HKD","LU1232071149.USD","LU1548497426.USD","LU2028103732.USD","LU0289739699.SGD","LU0820561909.HKD","LU2896262040.SGD","LU1093756168.USD","LU1623119135.USD","LU2087625088.SGD","LU2168563687.JPY","LU0471298694.HKD","LLII","LU2168564495.EUR","LU0354030438.USD","BK4534","IE0004445239.USD","IE00BJJMRY28.SGD","LU2236285917.USD","LU2552382132.HKD","SG9999014914.USD","LU0316494557.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","IE00B4JS1V06.HKD","LU0122379950.USD","LU0432979614.USD","SG9999015986.USD","LU2237443549.SGD","LU2756315664.SGD","LU2750360641.GBP","LU1061106388.HKD","LU1291159041.SGD","IE00BJLML261.HKD","IE00BK4W5L77.USD","LU0683600562.USD","LU1035775433.USD","LU2357305700.SGD","LU1127390331.HKD","LU1868836591.USD","LU0158827948.USD","LU0006306889.USD","LU0456855351.SGD","BK4581","LU0256863811.USD","LU1917777945.USD","LU2264538146.SGD","LU0198837287.USD","IE00B1BXHZ80.USD","LU2491050154.USD","LLYX","LU2112291526.USD","LU0689472784.USD","LU2471134523.USD","LU1057294990.SGD","SG9999001176.SGD","LU2237438978.USD","LU2168564222.USD","GB00BDT5M118.USD","IE00BFSS8Q28.SGD","SG9999015952.SGD","LU1323610961.USD","LU0640476718.USD","LU2111349929.HKD","LU0058720904.USD","LU0097036916.USD","LU1804176565.USD","BK4139","IE00B7KXQ091.USD","IE00B4R5TH58.HKD","LU0203202063.USD","IE00BN29S564.USD","LU2023251221.USD","LU0466842654.USD","LU1868836914.USD","LU2361044865.SGD","SG9999018857.SGD","LLY","LU0158827781.USD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640360138","title":"H.C. Wainwright Sticks to Their Buy Rating for Altimmune (ALT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640360138","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640360138?lang=en_us&edition=fundamental","pubTime":"2026-06-04 08:11","pubTimestamp":1780531912,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Patrick Trucchio from H.C. Wainwright maintained a Buy rating on Altimmune, with a price target of $20.00. Accordin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-altimmune-alt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-altimmune-alt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640090944","title":"TG Therapeutics Announces Positive Results from Phase 1 Trial Evaluating Subcutaneous BRIUMVI® (ublituximab-xiiy)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640090944","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640090944?lang=en_us&edition=fundamental","pubTime":"2026-06-03 19:30","pubTimestamp":1780486200,"startTime":"0","endTime":"0","summary":"Pharmacokinetic and pharmacodynamic data support quarterly subcutaneous BRIUMVI dosing regimen currently under evaluation in fully enrolled Phase 3 trial; Top-line Phase 3 data expected year-end 2026 ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/03/3305943/8790/en/TG-Therapeutics-Announces-Positive-Results-from-Phase-1-Trial-Evaluating-Subcutaneous-BRIUMVI-ublituximab-xiiy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PK","BK4153","LU1720051108.HKD","PML","LU0795875169.SGD","LU1074936037.SGD","LU1169590202.USD","LU0098860793.USD","ALT","LU2271345857.HKD","TGTX","LU1548497426.USD","BK4588","LU2347655156.SGD","LU0158827781.USD","LU0106831901.USD","LU1732799900.SGD","CNS","LU1244550577.SGD","LU0882574139.USD","LU1668664300.SGD","LU1363072403.SGD","BK4504","BK4023","PD","LU0390134368.USD","LU1878469433.USD","LU0912757837.SGD","IE00BZ1G4Q59.USD","BK4581","BK4599","LU1064131342.USD","LU2264538146.SGD","HCP","LU2028103732.USD","BK4156","LU0971096721.USD","LU0006306889.USD","LU1169589451.USD","TG","LU1162221912.USD","LU0210528500.USD","LU0320765646.SGD","BK4090","LU1244550221.USD","LU1988902786.USD","BK4585","LU0106261372.USD","BK4181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640959805","title":"TG Therapeutics Announces Publication of Post-Hoc Data from the Phase 3 ULTIMATE I & II Trials in Treatment Naive Patients with Relapsing Forms of MS Published in Frontiers in Immunology","url":"https://stock-news.laohu8.com/highlight/detail?id=2640959805","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640959805?lang=en_us&edition=fundamental","pubTime":"2026-06-01 19:30","pubTimestamp":1780313400,"startTime":"0","endTime":"0","summary":"Treatment with BRIUMVI reduced annualized relapse rate by 56.7% vs. teriflunomide in treatment-nave patients  BRIUMVI demonstrated significant improvements across disability, MRI outcomes, and no evid","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/01/3304240/8790/en/TG-Therapeutics-Announces-Publication-of-Post-Hoc-Data-from-the-Phase-3-ULTIMATE-I-II-Trials-in-Treatment-Naive-Patients-with-Relapsing-Forms-of-MS-Published-in-Frontiers-in-Immuno.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PML","LU1989772923.USD","BK4212","LU0225283273.USD","LU0528227936.USD","LU1548497426.USD","LU2028103732.USD","BK4153","POST","LU0390134368.USD","ARR","LU2023251221.USD","ALT","LU0106261372.USD","BK4223","LU0234570918.USD","LU0795875086.SGD","LU1791710582.SGD","LU1668664300.SGD","HCP","LU0053666078.USD","LU1244550221.USD","LU1363072403.SGD","LU2264538146.SGD","CDP","TG","LU2347655156.SGD","LU0314104364.USD","LU1720051017.SGD","LU0267386448.USD","LU0158827948.USD","LU1064131342.USD","LU1791710400.SGD","BK4139","LU1732800096.USD","IE00BKVL7J92.USD","CNS","LU0158827781.USD","LU1732799900.SGD","LU2089283258.USD","IE00BZ1G4Q59.USD","LU0882574139.USD","BK4090","TGTX","LU1988902786.USD","BK4127","LU2271345857.HKD","BK4585","LU1989772840.SGD","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639697408","title":"Altimmune reports 48-week data from IMPACT Phase 2b trial of pemvidutide","url":"https://stock-news.laohu8.com/highlight/detail?id=2639697408","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639697408?lang=en_us&edition=fundamental","pubTime":"2026-05-29 00:27","pubTimestamp":1779985657,"startTime":"0","endTime":"0","summary":"Altimmune (ALT) announced that new 48-week data from the IMPACT Phase 2b trial show that pemvidutide, an investigational balanced glucagon/GLP-1 du...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/altimmune-reports-48-week-data-from-impact-phase-2b-trial-of-pemvidutide-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/altimmune-reports-48-week-data-from-impact-phase-2b-trial-of-pemvidutide-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","ALT","BK4139","LU1878469433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638927836","title":"Altimmune Says Pemvidutide Data Show Metabolic Improvements in MASH Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2638927836","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638927836?lang=en_us&edition=fundamental","pubTime":"2026-05-28 23:54","pubTimestamp":1779983663,"startTime":"0","endTime":"0","summary":"Altimmune  said Thursday new 48-week data from the Impact phase 2b trial show that pemvidutide, an investigational balanced glucagon/GLP-1 dual receptor agonist, significantly lowered elevated lipids while improving multiple cardio-metabolic risk factors in patients with metabolic dysfunction-associated steatohepatitis, or MASH.The findings demonstrated reductions in triglycerides and total cholesterol, along with improvements in weight, waist circumference and blood pressure, highlighting pemvidutide's efficacy on key drivers of MASH, the company said.The data was presented for the first time at the European Association for the Study of the Liver Congress 2026 in Barcelona, Spain.Results also showed that the safety profile of pemvidutide was maintained at 48 weeks and the tolerability profile was generally favorable without dose titration, the company added.Shares of Altimmune rose more than 3% in Thursday trading.Price: 3.07, Change: +0.09, Percent Change: +3.15","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALT","BK4599","LU1878469433.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638769429","title":"Analysts Offer Insights on Healthcare Companies: Altimmune (ALT), Icon (ICLR) and AIM ImmunoTech (AIM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2638769429","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638769429?lang=en_us&edition=fundamental","pubTime":"2026-05-28 23:00","pubTimestamp":1779980458,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Altimmune (ALT), Icon (ICLR) and AIM ImmunoTech (AIM...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-altimmune-alt-icon-iclr-and-aim-immunotech-aim-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-altimmune-alt-icon-iclr-and-aim-immunotech-aim-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0310800965.SGD","LU0289739343.SGD","LU0426412945.USD","LU0128525929.USD","LU2244417387.USD","BK4121","BK4532","LU0496365809.HKD","BK4581","HCSG","LU0128526141.USD","LU2362541513.USD","XLV","LU2362540622.SGD","LU1267930573.SGD","LU0128525689.USD","LU1267930813.SGD","LU0069063385.USD","XBI","LU1791710400.SGD","LU0882574055.USD","LU1043141396.HKD","LU0175139822.USD","LU0187121727.USD","LU0289961442.SGD","LU1804176565.USD","BK4139","LU0114720955.EUR","LU0211326839.USD","LU2362541273.HKD","LU0976567544.SGD","LU0511384066.AUD","BK4557","LU0057025933.USD","BK4599","BK4137","LU0889566641.SGD","ALT","LU0310800379.SGD","AIM","BK4588","LU0426417589.USD","BK4585","LU0052756011.USD","ICLR","LU1121112475.USD","LU0708994859.HKD","LU1983260115.SGD","LU0029864427.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638896516","title":"Altimmune's Phase 2b Trial Data for Pemvidutide Demonstrates Improvements in Liver Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2638896516","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638896516?lang=en_us&edition=fundamental","pubTime":"2026-05-27 22:34","pubTimestamp":1779892484,"startTime":"0","endTime":"0","summary":"Altimmune  said Wednesday that data from the phase 2b trial of pemvidutide to treat liver disease demonstrated improvements across non-invasive tests of metabolic dysfunction-associated steatohepatitis activity and fibrosis at 24 weeks compared with placebo.AI-based pathology showed that pemvidutide treatment led to considerable reductions in fibrosis values compared with placebo, according to a statement.The company will start patient enrollment for its phase 3 trial of the drug in H2 based on the latest phase 2b results, according to the company.Price: 2.99, Change: +0.06, Percent Change: +2.05","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4599","LU1878469433.USD","ALT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638070825","title":"Altimmune says pemvidutide shows fibrosis regression in MASH in IMPACT Phase 2b qFibrosis analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2638070825","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638070825?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:05","pubTimestamp":1779883502,"startTime":"0","endTime":"0","summary":"Altimmune disclosed new analyses from its IMPACT Phase 2b MASH trial, with results being presented at EASL 2026 in Barcelona.Pemvidutide showed broad improvement across non-invasive markers of disease activity and fibrosis versus placebo at 24 weeks.AI-based digital pathology supported fibrosis regression signals, reinforcing the drug’s antifibrotic profile.Altimmune plans to start enrolling patients in the PERFORMA Phase 3 pemvidutide trial in the second half of 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDLTQJQ2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4139","IE00BN0W2T93.GBP","LU0314104364.USD","NDAQ","LU1878469433.USD","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4585","BK4112","LU2210149790.SGD","SG9999014039.USD","IE00BN0W2V16.EUR","ALT","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","SG9999014021.USD","BK4588","LU2095319765.USD","IE00BKPKM429.USD","SG9999014005.SGD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638008507","title":"New IMPACT Phase 2b Data Highlight Concurrent Improvements Across Multiple Non-Invasive Markers and qFibrosis-Measured Fibrosis Regression with Pemvidutide in MASH at EASL 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2638008507","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638008507?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:00","pubTimestamp":1779883200,"startTime":"0","endTime":"0","summary":"Concurrent improvement across key non-invasive tests underscores convergence ofpemvidutide effects on MASH disease activity and fibrosis  AI-based digital pathology analyses further demonstrate antifi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/27/3301887/0/en/New-IMPACT-Phase-2b-Data-Highlight-Concurrent-Improvements-Across-Multiple-Non-Invasive-Markers-and-qFibrosis-Measured-Fibrosis-Regression-with-Pemvidutide-in-MASH-at-EASL-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0979878070.USD","LU0053671581.USD","SHG","BK4139","ALD","LU0566484027.USD","LU1242518857.USD","BK4207","LU1242518931.SGD","LU1559883803.SGD","LU1878469433.USD","ELF","ALT","BK4599","BK4183","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638502162","title":"TG Therapeutics Announces Positive Topline Results from Phase 3 ENHANCE Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2638502162","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638502162?lang=en_us&edition=fundamental","pubTime":"2026-05-27 19:30","pubTimestamp":1779881400,"startTime":"0","endTime":"0","summary":"Phase 3 trial met its primary endpoint, demonstrating bioequivalent drug exposure between the currently approved BRIUMVI Day 1 and Day 15 initiation dosing and a new single infusion on Day 1 only Safe","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/27/3301820/8790/en/TG-Therapeutics-Announces-Positive-Topline-Results-from-Phase-3-ENHANCE-Trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","LU1668664300.SGD","LU0006306889.USD","LU1791710582.SGD","LU2028103732.USD","HCP","LU2133065610.SGD","LU1878469433.USD","LU0210528500.USD","BK4516","LU2487616109.SGD","TGTX","LU0320765646.SGD","LU1064131342.USD","LU1732799900.SGD","LU1074936037.SGD","BK4023","PML","BK4599","LU0225283273.USD","LU0098860793.USD","ALT","LU1720051017.SGD","LU2089283258.USD","TG","LU0528227936.USD","BK4139","LU1988902786.USD","LU1732800096.USD","LU0912757837.SGD","LU1244550221.USD","LU1720051108.HKD","CNS","LU1244550577.SGD","LU2111349929.HKD","LU0158827781.USD","LU0882574139.USD","LU0557290698.USD","LU0795875086.SGD","LU1162221912.USD","BK4585","BK4588","LU2089284900.SGD","BK4504","LU0234570918.USD","LU0795875169.SGD","LU0053666078.USD","LU2264538146.SGD","LU0106831901.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638519729","title":"TG Therapeutics Announces Data Presentations for BRIUMVI® at the 2026 Consortium of Multiple Sclerosis Centers Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2638519729","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638519729?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:30","pubTimestamp":1779795000,"startTime":"0","endTime":"0","summary":"NEW YORK, May  26, 2026  (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI (ublituximab-xiiy) data in adults with re","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/26/3300974/8790/en/TG-Therapeutics-Announces-Data-Presentations-for-BRIUMVI-at-the-2026-Consortium-of-Multiple-Sclerosis-Centers-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1363072403.SGD","LU0053666078.USD","LU1548497426.USD","LU0314104364.USD","BK4504","LU0882574139.USD","LU1720051017.SGD","BK4599","LU1244550577.SGD","LU2487616109.SGD","TG","TGTX","BK4534","LU1989772923.USD","IE00BKVL7J92.USD","LU1732799900.SGD","LU2271345857.HKD","LU1668664300.SGD","ALT","BK4588","LU1162221912.USD","LU0098860793.USD","LU0971096721.USD","LU0234570918.USD","BK4581","LU0158827781.USD","LU2264538146.SGD","LU2357305700.SGD","BK4585","LU2089284900.SGD","CMSC","LU1791710582.SGD","LU0320765646.SGD","LU1988902786.USD","LU1244550494.USD","BK4516","LU2089283258.USD","CNS","LU1989772840.SGD","LU1878469433.USD","LU0557290698.USD","LU0912757837.SGD","IE00BZ1G4Q59.USD","PML","LU0106261372.USD","LU2111349929.HKD","LU0210528500.USD","LU0528227936.USD","LU0225283273.USD","LU1791710400.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636487856","title":"Several Insiders Invested In Altimmune Flagging Positive News","url":"https://stock-news.laohu8.com/highlight/detail?id=2636487856","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636487856?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:07","pubTimestamp":1779188871,"startTime":"0","endTime":"0","summary":"Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alt/altimmune/news/several-insiders-invested-in-altimmune-flagging-positive-new","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alt/altimmune/news/several-insiders-invested-in-altimmune-flagging-positive-new","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1878469433.USD","BK4599","BK4139","ALT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636351728","title":"U.S. RESEARCH ROUNDUP-Costco Wholesale, HCA Healthcare, Micron Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2636351728","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636351728?lang=en_us&edition=fundamental","pubTime":"2026-05-19 15:56","pubTimestamp":1779177409,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Costco Wholesale, HCA Healthcare, Micron TechnologyMay 19 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, in","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nL4N41W0N9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COSW","AGYS","AMAT","XYZG","D","HUN","LU2272731865.HKD","GOSS","INVH","FRT","BMRN","COTG","TILE","ALT","MU","MULL","COST","CSX","XYZ","AMT","AGL","THG","CYTK","ELMT","SJM","MUD","REGN","HCA","GPN","XYZY","ALNY","APO","BBIO","CTXR","CRWL","ELF","CRWD","BXSL","HOG","PGNY","BC","XE","FFIV","BFRI","AMH","MUU","ACM","ECL","ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636033860","title":"Altimmune Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2636033860","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636033860?lang=en_us&edition=fundamental","pubTime":"2026-05-19 01:54","pubTimestamp":1779126840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 18, 2026 13:54 ET (17:54 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT","LU1878469433.USD","BK4599","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":3,"totalSize":128,"code":"91000000","status":"200"}]}}